Cerus Corporation
CERS
$2.07
-$0.03-1.43%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
12/4/2025
-
Simply Wall St
11/28/2025
-
Simply Wall St
11/27/2025
-
GuruFocus
11/24/2025
-
Seeking Alpha - Long Ideas
11/24/2025
-
SeekingAlpha
11/8/2025
-
MarketBeat
11/8/2025
-
TipRanks Financial Blog
11/7/2025
-
MarketBeat
11/7/2025
-
GuruFocus
11/7/2025
-
GuruFocus
11/7/2025
-
SeekingAlpha.com: All News
11/7/2025
-
SeekingAlpha
11/7/2025
-
Seeking Alpha: Transcripts
11/6/2025
-
GuruFocus
11/6/2025
-
GuruFocus
11/6/2025
-
GuruFocus
11/6/2025
-
GuruFocus
11/6/2025
-
The Fly
11/6/2025
-
The Fly
11/6/2025
-
Business Wire
11/6/2025
-
TipRanks Financial Blog
10/30/2025
-
MarketBeat
10/26/2025
-
MarketBeat
10/21/2025
-
GuruFocus
10/21/2025
-
Business Wire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, November 6, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
925 288 6000
Address
1220 Concord Avenue
Concord, CA 94520
Concord, CA 94520
Country
Year Founded
Business Description
Sector
Industry
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System...
more